Best treatments for idiopathic pulmonary fibrosis
3 products may treat idiopathic pulmonary fibrosis, spanning FDA drug classes such as kinase inhibitor. The current highest-rated option is jascayd. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for idiopathic pulmonary fibrosis, 2 are available as lower-cost generics, spanning classes such as kinase inhibitor. 2 of 3 carry a safety score, from 72 to 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for idiopathic pulmonary fibrosis — so confirm the right choice with your prescriber.
Top-rated picks for idiopathic pulmonary fibrosis: 1. Jascayd · 2. Ofev · 3. Nintedanib Esylate
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Tablet | — | No data | — | View → | |
| 2 | 72/100 | Prescription | Capsule | Kinase Inhibitor | Generic | $485 | View → | |
| 3 | Not yet rated | Prescription | Capsule | Kinase Inhibitor | Generic | $485 | View → |
Narrow by drug class
Explore the class hubs: kinase inhibitor
Full ranking · 3 treatments
jascayd
PrescriptionFDA-sourced
Jascayd (Nerandomilast) is a medication used to treat Idiopathic Pulmonary Fibrosis.
Price varies
ofev
PrescriptionFDA-sourced
Ofev (Nintedanib Esylate) is a kinase inhibitor used to treat Idiopathic Pulmonary Fibrosis.
Pharmacy pays
~$485.32 /30
Save up to 95% in classnintedanib esylate
PrescriptionFDA-sourced
Nintedanib Esylate is a kinase inhibitor used to treat Idiopathic Pulmonary Fibrosis.
Pharmacy pays
~$485.32 /30
Save up to 95% in classFrequently asked
- What treats idiopathic pulmonary fibrosis?
- Our catalog lists 3 products that may treat idiopathic pulmonary fibrosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is jascayd.
- What is the best-rated treatment for idiopathic pulmonary fibrosis?
- By our independent recall-safety rating — not an efficacy measure — jascayd ranks highest among the products we list for idiopathic pulmonary fibrosis. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat idiopathic pulmonary fibrosis?
- Treatments for idiopathic pulmonary fibrosis span FDA drug classes including kinase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status